phase readout
saveNCT06823375: SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Chinese University of Hong Kong. Phase: PHASE2. Conditions: HCC
view source ↗Sponsor: Chinese University of Hong Kong. Phase: PHASE2. Conditions: HCC
view source ↗
comments(0)
5-min edit window · permanent after that